EGF anticorps (AA 609-751)
Aperçu rapide pour EGF anticorps (AA 609-751) (ABIN6777639)
Antigène
Voir toutes EGF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 609-751
-
Purification
- Affinity purified
-
Immunogène
-
Recombinant EGF (Ala609-Gly751) expressed in E. coli.
Type of Immunogen: Recombinant protein -
Isotype
- IgG
-
-
-
-
Indications d'application
-
Approved: WB (1:100 - 1:400)
Usage: ICC 5-30 μg/mL, WB 0.5-5 μg/mL, -
Commentaires
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- PBS, pH 7.4, 0.02 % sodium azide, 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C,-80 °C
-
Stockage commentaire
- Store frozen product at or below -20°C. Thawed product may be stored for 2-4 weeks at 4°C. For optimal storage, aliquot to smaller portions and store at -20°C to -70°C. Avoid freeze-thaw cycles.
-
-
- EGF (Epidermal Growth Factor (EGF))
-
Autre désignation
- EGF
-
Sujet
-
Name/Gene ID: EGF
Synonyms: EGF, Beta-urogastrone, HOMG4, URG, Epidermal growth factor, Pro-epidermal growth factor -
ID gène
- 1950
-
Pathways
- Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Antigène
-